1.Dose Characteristics of Stereotactic Radiosurgery in High Energy Linear Accelerator Photon Beam.
Journal of the Korean Society for Therapeutic Radiology 1992;10(2):137-146
Three-dimensional dose calculations based on CT images are fundamental to stereotactic radiosurgery for small intracranial tumor. In our stereotactic radiosurgery program, irradiations have been performed using the 6 MV photon beam of linear accelerator after stereotactic CT investigations of the target center through the beam's-eye view and the coordinates of BRW frame converted to that of radiosurgery. Also we can describe the tumor diameter and the shape in three dimensional configuration. Non-coplanar irradiation technique was developed that it consists of a combination of a moving field with a gantry angle of 140degree, and a horizontal couch angle of 200degreearound the isocenter In this radiosurgery technique, we provide the patient head setup in the base-ring holder and rotate around body axis. The total gantry moving range shows angle of 2520 degrees via two different types of gantry movement in a plane perpendicular to the axis of patient. The 3-D isodose cuties overlapped to the tumor contours in screen and analytic dose profiles in calculation area were provided to calculate the thickness of 80% of tumor center dose to 20% of that. Furtheremore we provided the 3-D dose profiles in entire calculation plane. In this experiments, measured isodose cuties in phantom irradiation have shown very similar to that of computer generations.
Axis, Cervical Vertebra
;
Family Characteristics
;
Head
;
Humans
;
Particle Accelerators*
;
Radiosurgery*
2.A Case of Malignant Pheochromocytoma in Child.
Seung Ok YANG ; Min Ho KANG ; Hyung Jin KIM ; Tae Sun PARK
Korean Journal of Urology 2000;41(6):799-802
No abstract available.
Child*
;
Humans
;
Pheochromocytoma*
3.A Case of Solitary Fibrofolliculoma.
Jin Kyung HONG ; Dou Hee YOON ; Tae Yoon KIM ; Hyong Ok KIM ; Chung Won KIM
Annals of Dermatology 1997;9(4):286-288
Fibrofolliculoma is a benign follicular neoplasm which usually occurs in multiple and rarely solitarily. We have found only seven cases of previous reports of solitary fibrofolliculomas worldwide and only two in Korean literature. Herein we report on a 40-year-old female patient with a solitary flesh-colored bean sized mass on the scalp which histopathologically proved to be a fibrofolliculoma.
Adult
;
Female
;
Humans
;
Scalp
4.Solitary Malignant Gastrointestinal Stromal Tumor Associated with a Neurofibromatosis Type I.
Hyun Jin MO ; Hyung Ok KIM ; Chung Won KIM ; Tae Yoon KIM
Annals of Dermatology 2003;15(1):12-14
From the Department of Dermatology, College of Medicine, The Catholic University of Korea, Kangnam St. Mary's Hospital, 505, Banpo-Dong, Seocho-Gu, 137-040, Seoul, Korea, Gastrointestinal stromal tumors are usually late manifestations of neurofibromatosis (von Recklinghausen's disease) and most become clinically apparent in middle-aged patients as multiple benign tumors. To our review of the literature, solitary malignant stromal tumor of gastrointestinal tract is exceptionally rare in von Recklinghausen's disease. We herein present a case of solitary jejunal stromal tumor in a 50-year-old woman with NF1, which histopathologically showed a malignant change and combined smooth muscle-neural type.
Dermatology
;
Female
;
Gastrointestinal Stromal Tumors*
;
Gastrointestinal Tract
;
Humans
;
Korea
;
Middle Aged
;
Neurofibromatoses*
;
Neurofibromatosis 1*
;
Seoul
5.Skeletal manifestation in congenital cytomegalic inclusion disease: a case report.
Myung Sang MOON ; In Young OK ; Hee Dai LEE ; Sung Tae KIM ; Jin Tack KIM
The Journal of the Korean Orthopaedic Association 1991;26(3):982-985
No abstract available.
Cytomegalovirus Infections*
6.Dose Characteristics of Total-Skin Electron-Beam Irradiation with Six-Dual Electron Fields.
Tae Jin CHOI ; Jin Hee KIM ; Ok Bae KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1998;16(3):337-345
PURPOSE: To obtain the uniform dose at limited depth to entire surface of the body, the dose characteristics of degraded electron beam of the large target-skin distance and the dose distribution of the six-dual electron fields were investigated. MATERIALS AND METHOD: The experimental dose distributions included the depth dose curve, spatial dose and attenuated electron beam were determined with 300 cm of target-skin distance (TSD) and full collimator size (35x35 cm2 on TSD 100 cm) in 4 MeV electron beam energy. Actual collimated field size of 105 cmx105 cm at the distance of 300 cm could include entire hemibody. A patient was standing on step board with hands up and holding the pole to stabilize his/her positions for the six-dual fields technique. As a scatter-degrader, 0.5 cm of acrylic plate was inserted at 20 cm from the body surface on the electron beam path to induce ray scattering and to increase the skin dose . RESULTS: The full width at half maximum (FWHM) of dose profile was 130 cm in large field of 105x105 cm2. The width of 100+/-10% of the resultant dose from two adjacent fields which were separated at 25 cm from field edge for obtaining the dose unifomity was extended to 186 cm. The depth of maximum dose lies at 5 mm and the 80% depth dose lies between 7 and 8 mm for the degraded electron beam by using the 0.5 cm thickness of acrylic absorber. Total skin electron beam irradiation (TSEBI) was carried out using the six dual fields has been developed at Stanford University. The dose distribution in TSEBI showed relatively uniform around the flat region of skin except the protruding and deeply curvatured portion of the body, which showed excess of dose at the former and less dose at the latter. CONCLUSION: The percent depth dose, profile curves and superimposed dosedistribution were investigated using the degraded electron beam through the beam absorber. The dose distribution obtained by experiments of TSEBI showed within+/-10% difference except the protruding area of skin which needs a shield and deeply curvatured region of skin which needs boosting dose.
Hand
;
Humans
;
Skin
7.The Topical Intraperitoneal Anesthesia of 0.5% Bupivacaine Before Laparoscopic Cholecystectomy is Effective on the Postoperative Pain Control.
Mi Ja SEOUK ; Seung Ok HWANG ; Gwan Woo LEE ; Bong Jin KANG ; Seok Kon KIM ; Tae Jin KIM
Korean Journal of Anesthesiology 1997;33(6):1103-1108
BACKGROUND: Recently, laparoscopic cholecystectomy becomes more favorite method than traditional open cholecystectomy. But postoperative pain control is still remaining problem. METHOD: Patients scheduled for elective laparoscopic cholecystectomy were assigned to two groups by simple randomization (15 patients per group). Group C (control) had no specific treatment and group B (bupivacaine) received 20 ml of 0.5% bupivacaine with epinephrine 1:200,000 before surgery. Immediately after the creation of a pneumoperitoneum, the surgeon sprayed the bupivacaine near and above the operation field. Operation was started 10 minutes after then. We attempted to investigate that the degree of postoperative pain which was assessed using the visual analogue scale (VAS) and the verbal rating scale (VRS) in the recovery room at postoperative 1 h., as well as the analgesic requirements during the first 24 h. postoperatively. RESULT: VRS of group B was significantly lower than group C (p<0.05), but VAS was not significantly different. Six patients in group B and only one in group C requested no analgesics. Group C had statistically more frequent request for analgesics than group B (p<0.05). CONCLUSION: The topical intraperitoneal anesthesia of 20 ml of 0.5% bupivacaine with epinephrine 1 : 200,000 before laparoscopic cholecystectomy is effective on the postoperative pain control. So, we recommmend that this simple and effective management is routinely treated in patients undergoing laparoscopic cholecystectomy.
Analgesics
;
Anesthesia*
;
Bupivacaine*
;
Cholecystectomy
;
Cholecystectomy, Laparoscopic*
;
Epinephrine
;
Humans
;
Pain, Postoperative*
;
Pneumoperitoneum
;
Random Allocation
;
Recovery Room
8.Development of a New Radiotherapy Technique using the Quasi-conformation Method.
Tae Jin CHOI ; Jin Hee KIM ; Ok Bae KIM
Journal of the Korean Society for Therapeutic Radiology 1991;9(2):343-350
The quasi-conformation therapy was performed to get a homogeneous dose distributions for irregeular shaped tumor lesion by using the arc moving beam and beam modifying filer which was made by cerrobend alloy (p=9.4g/cc) metal. In our dose calcuation programme, it was fundmentally based on Clarkson's method to calcuate the irregular multi-step block field in rotation therapy. In this study, the expected relative depth doses under multipartial attenuator agree well with measured data at same plane. The results of comparison the dose computation with that of TLD measurement are very closed within +/-5% uncertainties in the irradiation to phantom with quasi-comformation method. And it has shown that irregular typed multi-step filter can be applied to quasi-conformation therapy in high energy radiation plannings.
Alloys
;
Radiotherapy*
9.Treatment of Early Glassy Cell Carcinoma of Uterine Cervix.
Ok Bae KIM ; Jin Hee KIM ; Tae Jin CHOI
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2006;24(2):123-127
PURPOSE: The purpose of this study was to investigate the clinical findings, treatment, and outcome of patients with glassy cell carcinoma of cervix. MATERIALS AND METHODS: We reviewed all cases of glassy cell carcinima of the uterine cervix confirmed and treated at the Dongsan Medical Center, Keimyung University, between January 1993 and December 2005. There were 7 cases with histopathologically confirmed gassy cell carcinoma. A tumor was diagnosed as glassy cell carcinoma if over 50% of the tumor cell type displayed glassy cell features. Six patients with stage IB had radical hysterectomy and bilateral pelvic node dissection, and 2 of them received adjuvant external pelvic irradiation with concurrent chemotherapy. Remaining one patient with stage IIA had curative concurrent chemoradiotherapy with external pelvic irradiation and brachytherapy. RESULTS: There were 7 patients diagnosed as glassy cell carcinoma among the 3,745 (0.2%) patients of carcinoma of uterine cervix. The mean age of 7 patients was 44 years with range of 35 to 53 years of age. The most frequent symptom was vaginal bleeding (86%). By the punch biopsy undertaken before treatment of 7 cases, 2 only cases could diagnose as glassy cell carcinoma of uterine cervix, but remaining of them confirmed by surgical pathological examination. The mean follow up duration was 73 months with range of 13 to 150 months. All 7 patients were alive without disease after treatment. CONCLUSION: Glassy cell carcinoma of the uterine cervix is a distinct clinicopathologic entity that demonstrates an aggressive biologic behavior. However for early-stage disease, we may have more favorable clinical outcome with radical surgery followed by chemoradiothery.
Biopsy
;
Brachytherapy
;
Cervix Uteri*
;
Chemoradiotherapy
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Hysterectomy
;
Uterine Hemorrhage
10.Results of Radiation Alone Versus Neoadjuvant Chemotherapy and Radiation in Locally Advanced Stage of Uterine Cervical Cancer.
Jin Hee KIM ; Tae Jin CHOI ; Ok Bae KIM
Journal of the Korean Society for Therapeutic Radiology 1997;15(3):255-262
PURPOSE: This is retrospective study to compare the results of radiation therapy alone and neoadjuvant chemotherapy and radiation in advanced stage of uterine cervical cancer. MATERIALS AND METHODS: Seventy-six patients who were treated with definitive radiation therapy for locally advanced cervical cacinoma between June 1988 and December 1993 at the department of radiation oncology, Keimyung University Dong-san Hospital. Thirty six patients were treated with radiation therapy alone and forty patients were treated with cisplatin based neoadjuvant chemotherapy and radiation therapy. According to FIGO staging system, there were 48 patients in stage IIb, 3 patients in stage IIIa, 23 patients in stage IIIb and two patients in stage IVa with median age of 53 years old. Follow-up periods ranged from 7 to 95 months with median 58 months. RESULTS: Complete response (CR) rate were 86.1% in radiation alone group and 80% in chemoradiation group. There was no statistical difference in CR rate between the two groups. Overall five-year survival rate was 67.3%. According to stage, overall five-year survival rates were 74% in stage IIb, 66.7% in stage IIIa, 49.8% in stage IIb, 50% in stage IVa. According to treatment modality overall five year survival rates were 74.1% in radiation alone and 61.4% in chemoradiation group (P=0.4). Five year local failure free survival rates were 71.5% in radiation alone group and 60% in chemoradiation group (P=0.17). Five year distant metastasis free survival rates were 80.7% in radiation alone group and 89.9% in chemoradiation group (P=0.42). Bone marrow suppression (more than grade II) was noted in 4 patients (11.1%) of radiation alone and 9 patients (22.5%) of chemoradiation group. Grade II vesical complication was noted in 3 cases of radiaion alone group and 1 case of chemoradiation group. Grade II retal complication was noted in 5 patients of radiation group and 4 patients in chemoradiation group. Bowel obstruction treated with conservative treatment (1 patient) and bowel perforation treated with surgery (1 patient) were noted in radiation alone group. There was no statistical difference in complication between two groups. CONCLUSION: There was no statistical difference in survival, failure and complication between neoadjuvant chemotherapy and radiation versus radiation alone in locally advanced uterine cervical carcinoma.
Bone Marrow
;
Cisplatin
;
Drug Therapy*
;
Follow-Up Studies
;
Humans
;
Middle Aged
;
Neoplasm Metastasis
;
Radiation Oncology
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms*